This study, by integrating MR analysis, mediation analysis, public transcriptomic data, and single‐cell transcriptomic data, systematically reveals the causal mechanism by which CCNE1 reduces PD risk through the genetically driven upregulation of PARP16 expression, inhibiting the ferroptosis pathway. The gene discussed is CCNE1; the disease is Parkinson disease.